Manufacturing and Production

Showing 15 posts of 5871 posts found.

Avacta’s COVID-19 lateral flow test gains clinical validation

April 20, 2021 Manufacturing and Production COVID-19

Avacta have announced positive data from the clinical validation of its AffiDX SARS-CoV-2 antigen lateral flow test, based on a …
AstraZeneca sign

AstraZeneca’s Farxiga falls short in Phase III trials for treatment of COVID-19

April 13, 2021 Manufacturing and Production AstraZeneca, COVID-19, covid-19 treatment, farxiga, pharma, pharma news

AstraZeneca’s Farxiga drug, usually used in patients with diabetes, did not show statistical significance in the Phase III trial into …

Regeneron’s drug cocktail shown to prevent symptomatic COVID-19

April 13, 2021 Manufacturing and Production COVID-19, REGEN-COV, Regeneron, covid-19 treatment, pharma, pharma news

Regeneron’s REGEN-COV treatment cocktail for COVID-19, a combination between casirivimab and imdevimab, has shown a significant reduction in progression to …
pexels-lucy-6816451_cropped

Asthma drug Budesonide helps COVID-19 recovery at home

April 13, 2021 Manufacturing and Production COVID-19, asthma drug

Budesonide, a widely-used asthma drug, is the first treatment to be proven to speed up the recovery of COVID-19 patients …

BC Platforms partners with Australian Tissue Bank to improve breast cancer treatment

April 13, 2021 Manufacturing and Production Cancer, data

BC Platforms have announced a data partnership with the Australian Breast Cancer Tissue Bank (ABCTB) for its BCRQUEST.com Global Data …

Akari Therapeutics open IND with FDA for bullous pemphigoid treatment

April 13, 2021 Manufacturing and Production FDA

Akari Therapeutics have opened an investigational new drug application (IND) with the FDA for its multicentre Phase III study with …

Intravac appoints Nathalie Laarakker as CFO

April 7, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Intravac have announced the appointment of Nathalie Laarakker as its new CFO and member of the company’s executive management team. …

Smithers promotes Nikki Lucas to Principal Project Manager

April 7, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Nikki Lucas has been appointed Principal Project Manager within Smithers’ Medical Device Physical Testing team. Lucas has over a decade …

New CEO appointed at Nordic Nanovector

April 7, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Nordic Nanovector have appointed Peter Braun as their new Chief Executive Officer. Braun is an experienced and entrepreneurial pharmaceutical leader, …
chas_taylor

Ceryx Medical announce new chairman Chas Taylor

April 7, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Cardiovascular technology company Ceryx Medical have appointed Chas Taylor as their new chairman. The appointment comes at an interesting time …

Valneva’s inactivated COVID-19 vaccine candidate advances to Phase III trial

April 6, 2021 Manufacturing and Production COVID-19, COVID-19 vaccine, Valneva, Valneva vaccine, inactivated vaccine

Specialty vaccine company Valneva’s inactivated COVID-19 jab has shown positive results in a Phase I/II trial, with a seroconversion rate …
Janssen sign

Janssen agrees $780 million deal for authorisation of Cidara flu treatment

April 6, 2021 Manufacturing and Production Janssen, cidara, influenza

Janssen has struck a deal worth up to $780 million with Cidara Therapeutics for exclusive worldwide rights to Cidara’s CD388 …
Pfizer's Lipitor tablet

Pfizer vaccine 91.3% effective after six months, Phase III study shows

April 6, 2021 Manufacturing and Production BioNTech, COVID-19, COVID-19 vaccine, Pfizer, Pfizer vaccine, pfizer-biontech vaccine

Pfizer and BioNTech’s follow-up study of their COVID-19 vaccine has confirmed the jab’s high efficacy after up to six months, …

Alnylam publish successful results from Phase III study of ultra-rare disease

April 6, 2021 Manufacturing and Production

Alnylam Pharmaceuticals, a RNAi therapeutics company, have published successful results from their Phase III study of lumasiran, the first ever …

FDA approves first new ADHD drug in a decade

April 6, 2021 Manufacturing and Production ADHD, FDA, paediatric

The FDA have approved the first new drug for the treatment of attention deficit hyperactivity disorder (ADHD) in over a …
The Gateway to Local Adoption Series

Latest content